Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANWATCH: Adjuvant Chemotherapy vs Wait and Watch in Down-staged Colorectal Cancer
NCT03748485Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Apr 2019
- Primary completion
- Dec 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, open-label trial of mFOLFOX6 in colorectal cancer (CRC) (2 arms), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Primary endpoint: Disease-Free Survival at 3 years. Started Apr 2019; status: recruiting.
02
Drugs
mFOLFOX6
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03748485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748485.